Dr. Neha Mishra
“Cost should never be the reason a patient stops taking the right medication. The evidence has to be honest, and so does the price tag.”
A Working Clinician Reviewing Patient-Facing Drug Content
Dr. Neha Mishra is a practicing Infectious Disease consultant at Manipal Hospital, Old Airport Road, Bangalore, where she also serves as Head of Department for Infectious Diseases. Her clinical work spans HIV care, treatment of immunocompromised patients (including post-transplant infections), tropical infectious diseases, antimicrobial stewardship, and complex tuberculosis including multi-drug-resistant and extensively drug-resistant TB. She has been in active clinical practice since 2004.
Dr. Mishra completed her MBBS at Kamineni Institute of Medical Sciences in Narketpally, followed by an MD in Internal Medicine from Maharishi Markandeshwar Institute of Medical Sciences and Research (MMU, Ambala). She undertook her Post-Doctoral Fellowship in Infectious Diseases at Christian Medical College, Vellore — one of the most rigorous infectious disease training programs in South Asia — and additionally holds a Postgraduate Diploma in Infectious Diseases jointly affiliated with the University of New South Wales and Medvarsity. Before joining Manipal, she was associated with GTB Hospital and University College of Medical Sciences (Delhi University) and worked as Assistant Professor at Sharda University.
As Medical Reviewer for SunnyPharma®, Dr. Mishra evaluates patient-facing drug content against current prescribing information, peer-reviewed literature, and established treatment guidelines including DHHS Adult ARV Treatment Guidelines, AASLD/IDSA HCV Guidance, and WHO HIV recommendations. Her role is specifically to verify that information about medications, regimens, side effects, and access pathways is clinically accurate before publication. She does not write SunnyPharma® articles — her function is independent review.
In my clinic I see patients who skip doses because the bottle is too expensive that month. The pharmacology doesn’t change because someone is poor. What needs to change is how clearly we tell people what their actual options are.
Public Clinical Commentary & Press Contributions
Dr. Mishra is regularly cited in Indian and international press on infectious disease topics including HIV care, vaccine policy, TB elimination, antimicrobial resistance, and emerging infections. A representative selection of her public clinical commentary:
-
“Prioritise cancer, HIV patients” — guidance on protecting immunocompromised populations during respiratory virus surges
-
Adult immunization & vaccination beyond childhood — panel contributor
-
“Tuberculosis in the era of COVID-19” — clinical commentary on TB program disruption and recovery
-
Dengue, chikungunya & tropical infections — recurring expert source
-
Antimicrobial stewardship in everyday clinical practice — public health commentary
-
Seasonal flu, viral fevers & community infection patterns in Bengaluru
How Dr. Mishra Reviews SunnyPharma® Content
Every article assigned for medical review is checked against three reference layers in sequence: (1) the current FDA-approved Prescribing Information for the drug in question, (2) the most recent guideline statements from the relevant authority — DHHS for HIV antiretrovirals, AASLD/IDSA for HCV direct-acting antivirals, WHO for global HIV recommendations, IDSA for general infectious disease, and (3) recent peer-reviewed literature on real-world outcomes, particularly in cost-burdened and treatment-experienced populations. Where guidelines and real-world data conflict, both are presented and the conflict is named — not smoothed over.
Conflict of interest disclosure. Dr. Mishra has no financial relationships with any antiretroviral, antiviral, or weight management pharmaceutical manufacturer. She receives a fixed per-article review fee from SunnyPharma®, paid regardless of the article’s conclusions, recommendations, or commercial outcomes. She is not compensated for referrals, traffic, or any user action taken on the SunnyPharma® platform.
Independence boundary. SunnyPharma® is an independent health education platform — not a pharmacy, not a seller, not affiliated with any manufacturer. Dr. Mishra’s clinical practice in Bangalore is entirely separate from her SunnyPharma® review work. No SunnyPharma® content is directed to patients under her direct clinical care.